Physician profile
Mark Joseph Pidala
NPI 1417960550
$5,817.82
in general payments reported to CMS, 2019-2025
17 companies · $803 in 2025
The $803 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,203 · 2020: $2,256 · 2021: $124 · 2022: $310 · 2023: $396 · 2024: $727 · 2025: $803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,925.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,488.47 | 2019-2025 | |
| Baxter Healthcare | $502.55 | 2019-2025 | Perclot |
| Thd America, INC. | $429.24 | 2022-2024 | |
| Ethicon US, LLC | $378.30 | 2019-2025 | Echelon Flex, Smartablatetm System Rf Generator |
| Pacira Pharmaceuticals Incorporated | $353.49 | 2019-2025 | Exparel |
| Stryker Corporation | $247.78 | 2019 | |
| Becton, Dickinson and Company | $202.25 | 2024 | Hemosphere |
| Aroa Biosurgery Incorporated | $167.06 | 2025 | |
| Romark Laboratories, Lc | $145.41 | 2019 | |
| Davol INC. | $139.66 | 2023 | Arista Ah Flexitip |
| Edwards Lifesciences Corporation | $133.93 | 2019 | |
| Boston Scientific Corporation | $127.00 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $109.83 | 2025 | |
| Shire North American Group INC | $105.79 | 2019 | |
| Convatec INC. | $105.20 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $93.33 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Biom'Up Sa | $88.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Pidala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.